CFO Tobin Schilke sold $103K of Revance Therapeutics, Inc.

Sold$102,912

$32.15Price

3,201Shares

−5%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, Apr 3. Filed Tue, Apr 4, 12:24 PM ET, during the session. Not investment advice.